2004 Annual Meeting | Clinical Research Methods
| 09:00 AM - 09:50 AM |
Randomized Clinical Trials
Karl D. Kieburtz, MD |
|
| 09:50 AM - 10:35 AM |
Observational Studies
Anne T. Berg, PhD |
|
| 10:35 AM - 10:50 AM |
Discussion
|
|
| 10:50 AM - 11:00 AM |
Break
|
|
| 11:00 AM - 11:45 AM |
Sampling and Measurement Biases
Walter A. Rocca, MD, MPH |
|
| 11:45 AM - 12:00 PM |
Discussion
|
|
| 12:00 PM - 01:15 PM |
Lunch
|
|
| 01:15 PM - 02:00 PM |
Random Error, Confounding, and Effect Modification
George Howard, PhD |
|
| 02:00 PM - 02:45 PM |
Health Services Research: Quality of Care and Outcomes Research
Gretchen L. Birbeck, MD, MPH, DTMH, FAAN |
|
| 02:45 PM - 03:00 PM |
Discussion
|
|
| 03:00 PM - 03:15 PM |
Break
|
|
| 03:15 PM - 04:00 PM |
Decision Analysis and Cost-Effectiveness Research
S. C. Johnston, MD, PhD, FAAN |
|
| 04:00 PM - 04:45 PM |
Legal and Ethical Issues in Clinical Research
Edward Goldman, JD |
|
| 04:45 PM - 05:00 PM |
Questions and Answers
|
| Walter A. Rocca, MD, MPH | The institution of Dr. Rocca has received research support from National Institute on Aging - NIH. The institution of Dr. Rocca has received research support from National Heart, Lung, and Blood Institute - NIH. |
| Karl D. Kieburtz, MD | Dr. Kieburtz has received personal compensation for serving as an employee of Clintrex Research Corporation. Dr. Kieburtz has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Kieburtz has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lilly. Dr. Kieburtz has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Janssen. Dr. Kieburtz has stock in Clintrex Research Corp. Dr. Kieburtz has stock in Hoover Brown. An immediate family member of Dr. Kieburtz has stock in Hoover Brown. Dr. Kieburtz has stock in Safe Therapeutics. The institution of Dr. Kieburtz has received research support from NIH. The institution of Dr. Kieburtz has received research support from Michae J Fox Foundation. |
| S. C. Johnston, MD, PhD, FAAN | No disclosure on file |
| Anne T. Berg, PhD | Dr. Berg has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biohaven. Dr. Berg has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Berg has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Encoded. Dr. Berg has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biomarin. The institution of Dr. Berg has received research support from FamilieSCN2A Foundation. |
| Gretchen L. Birbeck, MD, MPH, DTMH, FAAN | An immediate family member of Dr. Birbeck has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Various. Dr. Birbeck has a non-compensated relationship as a Ambassador for Zambia with RSTMH that is relevant to AAN interests or activities. |
| Edward Goldman, JD | No disclosure on file |
| George Howard, PhD | Dr. Howard has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bayer. |
| No disclosure on file |